Friday, February 28, 2020
-
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO (ABIO, ABMD, ACHV, ACOR, ACRX, ACST, ADIL, AERI, AKER, ALDX, ALXN, ANCN, ANGO, ANIP, APVO, ARNA, ARTL, ATRA, AUTL, AVEO, AXDX, AYTU, BDTX, BHVN, BIIB, Biotech, BLUE, BNTC, BPMC, BSGM, CARA, CASI, CBLI, CDXS, CEMI, CHMA, CHRS, CNSP, CO, CODX, CPIX, Earnings, EARS, EDSA, EKSO, ELOX, ENTA, EOLS, ETON, GALT, GERN, GILD, GLYC, GNCA, GNMK, GOSS, GRTX, HTBX, HTGM, IBB, ILMN, IONS, KMPH, KRMD, KTOV, KURA, MACK, MBRX, MDGS, MDWD, MITO, MNLO, MNOV, MRKR, MRNA, MRSN, MSON, MTP, MYGN, MYL, NCNA, News, NOVN, NURO, OBLN, OFIX, OMER, ONCS, PACB, PDSB, PGEN, PLSE, POAI, PRPO, PSTV, PTLA, RDHL, RDUS, REGN, SAGE, SESN, SGMO, SLDB, SNOA, SPPI, SRDX, STIM, STML, TARO, TCON, THTX, TTPH, TXMD, VIR, VKTX, VVUS, VYGR, XBI, XERS, ZGNX, ZYNE, ZYXI, Guidance, Offerings, Contracts, FDA, IPOs, Top Stories, Pre-Market Outlook, Trading Ideas / Fri, 07:28am)
